Dr. Moran is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
QED Therapeutics
Brisbane, CA 94005Phone+1 650-231-4088
Education & Training
University of Pennsylvania Health SystemResidency, Internal Medicine, 1995 - 1998
Duke University School of MedicineClass of 1995
Certifications & Licensure
MA State Medical License 2001 - 2026
CA State Medical License 2015 - 2025
PA State Medical License 1996 - 2002- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 6 citationsInfigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic Urothelial Carcinoma.Yung Lyou, Jonathan E. Rosenberg, Jean H. Hoffman-Censits, David I. Quinn, Daniel P. Petrylak
Clinical Genitourinary Cancer. 2021-10-13 - 171 citationsInfigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multice...Milind Javle, Sameek Roychowdhury, Robin Kate Kelley, Saeed Sadeghi, Teresa Macarulla
The Lancet. Gastroenterology & Hepatology. 2021-10-01 - 22 citationsTargeted FGFR Blockade for the Treatment of Tumor-Induced Osteomalacia.Iris R Hartley, Carole B. Miller, Georgios Z. Papadakis, Clemens Bergwitz, Jaydira Del Rivero
The New England Journal of Medicine. 2020-09-09
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
